Heather D Turner insider trades: Atara Biotherapeutics (ATRA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Heather reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 9, 2018 | ATRA | ↓ Sell | 12,214 | $38.01 | $464K | Direct | Feb 12, 2018 (3d) |
| Feb 9, 2017 | ATRA | ↓ Sell | 12,215 | $15.72 | $192K | Direct | Feb 10, 2017 (1d) |
| Dec 2, 2014 | OREX | ↓ Sell | 22,643 | $6.00 | $136K | Direct | Dec 4, 2014 (2d) |
| Nov 25, 2014 | OREX | ↓ Sell | 31,388 | $5.83 | $183K | Direct | Nov 26, 2014 (1d) |
| Sep 22, 2014 | OREX | ↓ Sell | 300,000 | $4.46 | $1.3M | Direct | Sep 22, 2014 (0d) |
| Jul 17, 2012 | OREX | ↓ Sell | 82,433 | $7.68 | $633K | Direct | Jul 19, 2012 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ATRA insiders
Open-market trades in the last 12 months
About Heather D Turner's insider trades
Heather D Turner is Former EVP, GC & Sec. at Atara Biotherapeutics (ATRA). Since Jul 17, 2012, Heather has reported no open-market purchases and 6 sales worth $2.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (27 filings), shares returned to the company (4 filings), option exercises (4 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.